PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2008
| PHARMANIAGA BERHAD |
|
Financial Year End | 31/12/2008 |
| Quarter | 2 |
| Quarterly report for the financial period ended | 30/06/2008 |
| The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2008 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2008 | 30/06/2007 | 30/06/2008 | 30/06/2007 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 353,465 | 300,231 | 663,115 | 556,466 |
| 2 | Profit/(loss) before tax | 21,088 | 12,181 | 48,462 | 22,411 |
| 3 | Profit/(loss) for the period | 13,457 | 7,217 | 32,439 | 13,710 |
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 13,107 | 6,640 | 31,652 | 12,709 |
| 5 | Basic earnings/(loss) per share (sen) | 12.25 | 6.21 | 29.59 | 11.88 |
| 6 | Proposed/Declared dividend per share (sen) | 18.00 | 15.00 | 18.00 | 15.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net assets per share attributable to ordinary equity holders of the parent (RM) | 3.3900 | 3.2700 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
| Remarks : |
| No interim ordinary dividend has been declared for the financial period ended 30 June 2008 (2007 : nil). A final tax exempt dividend of 18.0% (2006 : 15.0%) on 106,963,188 (2006 : 106,963,188) ordinary shares of RM1.00 each in respect of the previous financial year amounting to RM19,253,374 (2006 : RM16,044,478) was approved by shareholders on 22 May 2008 and paid on 2 July 2008. |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 14 Aug 2008 |
| Category | Financial Results |
| Reference No | PB-080813-32637 |